The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.
Christmas gift for Stage 2B and 2C melanoma patients
FDA approves pembrolizumab for adjuvant treatment of Stage IIB or IIC melanoma. On <b>December 3, 2021</b>, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) for the adjuvant treatment of adult and pediatric (≥12 years of age) patients with stage IIB or IIC melanoma following complete resection
I remember asking the doctor to give me Nivo or something similar when I was stage 2c and scared. He said he wasn’t allowed. Well, I went on to stage 4 after that!
Japan is quite a way behind North America in terms of treatment. The use of 480mg of Opdivo, which I am on, was only approved in December 2021.
Regards to everyone,
Viewing 0 reply threads
You must be logged in to reply to this topic.
About the MRF Patient Forum
The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.
The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.